CN Patent

CN1610551A — 用作止痛剂的6－羟基羟吗啡酮的肠胃外给药

Assigned to Endo Pharmaceuticals Inc · Expires 2005-04-27 · 21y expired

What this patent protects

在治疗疼痛的方法中，以足以诱导止痛的量向患者给以6－羟基羟吗啡酮的药物组合物。在一种实施方式中，药物组合物是肠胃外给药的，优选地借助注射和静脉内滴注。为了达到所需的止痛效果，6－羟基羟吗啡酮的血浆水平在治疗期间被提升至至少大约0.05ng/ml。以足以诱导止痛的量给以含有6－羟基羟吗啡酮和一种或多种载体、稀释剂和赋形剂的组合物也涵盖其中。

USPTO Abstract

在治疗疼痛的方法中，以足以诱导止痛的量向患者给以6－羟基羟吗啡酮的药物组合物。在一种实施方式中，药物组合物是肠胃外给药的，优选地借助注射和静脉内滴注。为了达到所需的止痛效果，6－羟基羟吗啡酮的血浆水平在治疗期间被提升至至少大约0.05ng/ml。以足以诱导止痛的量给以含有6－羟基羟吗啡酮和一种或多种载体、稀释剂和赋形剂的组合物也涵盖其中。

Drugs covered by this patent

Patent Metadata

Patent number
CN1610551A
Jurisdiction
CN
Classification
—
Expires
2005-04-27
Drug substance claim
No
Drug product claim
No
Assignee
Endo Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.